OmniAb (OABI) Receivables - Net (2021 - 2026)
OmniAb (OABI) posted quarterly Receivables - Net of $12.6 million for Q1 2026, up 95.11% year-over-year from $6.5 million in Q1 2025, and up 71.03% quarter-over-quarter from $7.4 million in Q4 2025.
OmniAb (OABI) Receivables - Net (2021 - 2026) Analysis & Trends
OmniAb (OABI) has reported Receivables - Net for 6 consecutive years, with $12.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Receivables - Net rose 95.11% year-over-year to $12.6 million; the TTM figure through Mar 2026 stood at $12.6 million (up 95.11% YoY), while the FY2025 annual figure was $7.4 million, up 40.17% from the prior year.
- Receivables - Net advanced to $12.6 million in Q1 2026 per OABI's latest filing, from $7.4 million in the prior quarter.
- Across five years, Receivables - Net topped out at $30.3 million in Q4 2022 and bottomed at $1.8 million in Q1 2023.
- Historically, Receivables - Net has averaged $7.3 million across 5 years, with a median of $5.7 million in 2023.
- Annual changes were most pronounced in 2023 — Receivables - Net plunged 87.31% — and 2024, when it soared 122.37%.
- OmniAb's Receivables - Net stood at $30.3 million in 2022, then slumped by 87.31% to $3.8 million in 2023, then jumped by 37.15% to $5.3 million in 2024, then soared by 40.17% to $7.4 million in 2025, then surged by 71.03% to $12.6 million in 2026.
- Business Quant data shows OABI's Receivables - Net at $12.6 million in Q1 2026, $7.4 million in Q4 2025, and $3.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | OmniAb | 491.42 Mn | 439.42 Mn | 12.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.33 Mn |
| Jun 30, 2026 | 10.33 Mn |
| Mar 31, 2026 | 12.64 Mn |
| Mar 31, 2026 | 12.64 Mn |
| Dec 31, 2025 | 7.39 Mn |
| Dec 31, 2025 | 7.39 Mn |
| Sep 30, 2025 | 3.10 Mn |
| Sep 30, 2025 | 3.10 Mn |
| Jun 30, 2025 | 2.71 Mn |
| Jun 30, 2025 | 2.71 Mn |
| Mar 31, 2025 | 6.48 Mn |
| Mar 31, 2025 | 6.48 Mn |
| Dec 31, 2024 | 5.27 Mn |
| Dec 31, 2024 | 5.27 Mn |
| Sep 30, 2024 | 3.50 Mn |
| Sep 30, 2024 | 3.50 Mn |
| Jun 30, 2024 | 6.88 Mn |
| Jun 30, 2024 | 6.88 Mn |
| Mar 31, 2024 | 4.05 Mn |
| Mar 31, 2024 | 4.05 Mn |